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Herpes simplex virus type 1 (HSV-1)-related disease ranges from a localized, self-limiting illness to fatal
disease in immunocompromised individuals. The corneal disease herpetic keratitis may develop after reacti-
vation of a latent virus or reinfection with an exogenous herpesvirus. Molecular analysis of the virus involved
may allow distinction between these two options. The HSV-1 genome contains several hypervariable regions
that vary in numbers of reiterating regions (reiterations I to VIII [ReI to ReVIII]) between individual strains.
Twenty-four HSV-1 clones, derived by subcloning of HSV-1 (strain F) twice in limiting dilutions, were tested
in a PCR-based assay to analyze the stabilities of ReI, ReIII, ReIV, and ReVII. ReI and ReIII proved to vary
in size upon subcloning, whereas ReIV and ReVII were stable. Subsequently, 37 unrelated isolates and 10
sequential isolates from five patients, all with HSV-1-induced keratitis, were genotyped for ReIV and ReVII. Of
the 37 unrelated samples, 34 (92%) could be discriminated, while the genotypes of the viruses in sequential
samples were identical for each individual. Conclusively, the data show that the approach presented allows the
rapid and accurate discrimination of HSV-1 strains in studies that address the transmission and pathogenesis
of HSV-1 infections.
Herpes simplex virus (HSV) type 1 (HSV-1) infections are
widespread in the human population and may cause a variety
of disease symptoms, including localized recurrent ocular le-
sions like uveitis and keratitis (16). Clinical manifestations
associated with herpetic corneal infections are herpetic epithe-
lial keratitis and the development of the potentially cornea-
blinding disease herpetic stromal keratitis.
It may be of clinical importance to know whether recurrent
corneal HSV-1 infections are caused by reactivation of a latent
virus or reinfection with an exogenous virus. Genetically dif-
ferent HSV-1 strains can induce different types of ocular le-
sions (8, 33). Intratypic differences between HSV strains have
been demonstrated by plaque morphology, serology, and DNA
restriction analysis (5, 15, 22). The method generally used to
discriminate HSV-1 strains is restriction fragment length poly-
morphism (RFLP) analysis (7, 15, 17–19, 24, 29–31). Since this
technique depends on virus culture to obtain sufficient quan-
tities of viral DNA, it is unsuitable for rapid diagnosis or when
no virus can be isolated. Vogel et al. (31) reported on an
alternative method for clinical HSV strain differentiation that
uses PCR amplification and subsequent RFLP analysis.
We have chosen to develop a different strategy, based on the
variability of reiterated sequences within the HSV-1 genome.
The genome of HSV-1 consists of a unique long (UL) and a
unique short (US) sequence, each of which is flanked by in-
verted repeat sequences (14, 32). Several hypervariable re-
gions, designated reiterations I to VIII (ReI to ReVIII), have
been identified within the HSV-1 genome (Fig. 1). These re-
gions contain multiple repeating sequences, which vary in num-
bers between unrelated HSV-1 strains (3, 9, 10, 13, 24, 25, 28,
34, 35). The stability of these regions varies. ReI, ReIII, ReIV,
and ReVII have been demonstrated to be relatively stable
during a short period of viral replication, and it has been
suggested that several of these hypervariable regions could be
used as markers to discriminate HSV-1 strains (27, 28). ReI
and ReIII are located within the “a” sequence of the repeat
regions that flank the unique short sequence. ReIV is present
twice within the HSV-1 genome and is located within introns of
both the genes US1 and US12, whereas ReVII is located within
the protein-coding region of US10 and US11 (3, 11, 13).
This report describes the development of a PCR method
that is used to discriminate HSV-1 strains and that is based on
the variability of reiterated sequences within the HSV-1 ge-
nome. This approach was successfully used to discriminate 37
unrelated corneal HSV-1 isolates obtained from patients with
herpetic corneal disease. Additionally, sequential HSV-1 iso-
lates from five herpetic keratitis patients were compared.
MATERIALS AND METHODS
Clinical samples and viruses. Corneal swab specimens were obtained from 37
patients with herpetic keratitis at the Rotterdam Eye Hospital (Rotterdam, The
Netherlands) for diagnostic purposes. Sequential samples (n 5 2) were obtained
(mean time interval, 19 months; range, 9 to 38 months) from 5 patients: from the
same eye for four patients and from different eyes for one patient. Virus was
grown on human embryonic lung fibroblasts and was harvested when approxi-
mately 75% of the monolayer displayed a cytopathic effect. All culture samples
were confirmed to be HSV-1 positive by PCR (data not shown). To determine
the stability of the hypervariable regions, 24 subclones were generated from
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HSV-1 F (ATCC VR-733) by subcloning twice in limiting dilution as described
before (26).
Nucleic acid extraction. DNA was extracted from 100 ml of virus culture
samples by a guanidinium thiocyanate-Celite binding method, as described be-
fore (1). Briefly, a sample was added to a tube containing 1 ml of lysis buffer and
40 ml of Celite suspension (Fischer Scientific, Den Bosch, The Netherlands),
mixed, and incubated for 10 min at room temperature. The Celite-bound DNA
was washed twice with wash buffer, twice with 70% (vol/vol) ethanol, and once
with acetone and was subsequently dried. DNA was extracted by resuspending
the pellet in 150 ml of water at 56°C for 10 min. A volume of 5 ml of the resulting
DNA suspension was used per PCR mixture.
PCR amplification. Primers were designed to amplify distinct regions in the
HSV-1 genome that contained ReI, ReIII, ReIV, or ReVII. PCR amplification
was performed with several combinations of primers (Table 1). The PCRs were
performed in 50-ml volumes. The reaction mixture contained 1.25 U of cloned
Pfu DNA polymerase (Stratagene Europe, Amsterdam, The Netherlands), cor-
responding buffer supplemented with 5% (vol/vol) dimethyl sulfoxide (DMSO),
each of the primers at a concentration of 1 mM, and each deoxynucleoside
triphosphate, including equimolar amounts of dGTP and 7-deaza-29-dGTP
(Boehringer Mannheim, Mannheim, Germany), at a concentration of 200 mM. A
5-ml sample of the DNA suspension was added, and the reaction mixtures were
overlaid with 50 ml of mineral oil. PCR amplification was carried out as follows:
an initial denaturation step of 95°C for 5 min, followed by 45 cycles of alternating
denaturation (1 min, 95°C), primer annealing (1 min at the appropriate temper-
ature; Table 1), and primer extension (1 min, 72°C). A final extension step of 7
min at 72°C was included. For negative control samples, the DNA suspension
was replaced by water. All PCRs were performed in a Perkin-Elmer 480 ther-
mocycler (PE Biosystems, Nieuwerkerk a/d IJssel, The Netherlands).
Detection of amplified products. Amplicons were size fractionated in 2%
agarose gels and were visualized by ethidium bromide staining. The specificities
of the amplicons were confirmed by Southern blotting (20). Briefly, the electro-
phoresed samples were transferred onto Hybond N1 membranes (Amersham,
Pharmacia Biotech). Hybridization was performed overnight at 37°C with
[g-32P]ATP-labeled Re-specific oligonucleotides (Table 1). Posthybridization
washes were performed twice with 23 SSC (13 SSC is 0.15 M NaCl plus 0.015
M sodium citrate)–0.1% sodium dodecyl sulfate at 37°C for 10 min. The filters
were exposed with intensifying screens at 280°C. In case of small differences in
length between amplicons from individual samples, the DNA fragments were
electrophoresed on denaturing (8 M urea) 6% acrylamide gels (20). The lengths
of the amplicons were estimated by comparison to a 100-bp DNA ladder (Gibco
BRL). To confirm differences in amplicon length, all samples tested were finally
electrophoresed in order of increasing length.
RESULTS
Amplification of hypervariable genomic HSV-1 regions con-
taining ReI, ReIII, ReIV, and ReVII. On the basis of docu-
mented variability and stability (27, 28), hypervariable regions
containing ReI, ReIII, ReIV, and ReVII were selected as
candidate templates for PCR-mediated discrimination of un-
related HSV-1 strains.
Amplification of these regions was not possible or was in-
sufficient under standard PCR conditions (data not shown).
FIG. 1. Map of HSV-1 genome and location and sequences of the reiterations tested. (A) The HSV-1 genome contains two covalently linked components (L and
S), each of which consists of unique sequences (UL and US) flanked by inverted repeat sequences (IR and TR). The short “a” sequence is located at both termini of
the genome and in the inverse orientation at the L-S junction (14). The enlargement of the S component shows the 59339 orientations of mRNA species as horizontal
arrows, with introns indicated as V-shaped indents. Protein-coding regions are shown as open boxes. Vertical arrows indicate locations of reiterations, and Roman
numerals indicate locations as defined by Rixon et al. (13). (B) Reiteration-specific sequences, as indicated by the superscript numbers, were derived from the indicated
HSV-1 strains: 1, MP17; 2, USA-8; 3, F.
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FIG. 2. Amplification of hypervariable regions within the HSV-1 genome. (A) PCR amplification of regions containing ReI, ReIII, ReIV, and ReVII was performed
with DNA from various HSV-1 (strain F) subclones. Amplicons were electrophoresed on a 2% agarose gel and were visualized by ethidium bromide staining. Ten
representative samples from 24 subclones analyzed are shown. Lane F, parental strain HSV-1 F; lanes 1 to 10, HSV-1 F subclones; lane C, water control; lanes M, 100-bp
molecular size marker. Numbers on the left are in base pairs. (B) Autoradiogram of DNA in gel from panel A after Southern blot transfer and hybridization with a
Re-specific probe.







Sequence (59339) Position in genomeb
“a” sequence ReIF 72 GCCGCCACCGCTTTAAAGGGCCGC 125976–125999 and 152234–152257
ReIR GTGCTCTGTTGGTTTCACCTGTGGCAGC 126368–126395 and 151838–151865
“a” sequence ReIIIF 72 TCTCTACCTCAGTGCCGCCAATCTCAGGTC 126742–126771 and 151462–151491
ReIIIR CGAAGACGCAATAAACGGCAACAACCTG 127171–127198 and 151035–151062
US1 ReIVUS1F 64 TCCGACGACAGAAACCCACC 132333–132352
ReIVUS1R GTCCCGGAGGACCACAGTGG 132615–132634
US12 ReIVUS12F 58 TTTTTGCACGGGTAAGCAC 145853–145871
ReIVUS12R TGGTGTCCAGGAAGGTGTCC 145535–145554
US10-US11 ReVIIUS1011F 56 AGCGTATGCTCCATGTTGTG 144697–144716
ReVIIUS1011R CGAGAACCTAGGGAACCCA 144928–144946
ReI ReI probe 37 CCGCTCCTCCCC
ReIII ReIII probe 37 CCGCCCCTCGCCCCCTC
ReIV ReIV probe 37 CCCCCTCCTCCACCCCCGCGTC
ReVII ReVII probe 37 CCCCGGTCTCCCCGGGAG
a F, forward; R, reverse.
b Positions correspond to the genomic HSV-1 sequence HE1CG (accession no. X14112).
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Alternative conditions, selected to decrease the formation of
secondary structures due to the high G1C contents of these
sequences, improved amplification of the target sequences and
allowed direct visualization of the amplicons with ethidium
bromide. The specificities of the amplicons were confirmed by
hybridization with a g-32P-labeled Re-specific probe following
Southern blotting (Fig. 2). Consistent results were obtained in
all cases in subsequent experiments.
To test the stabilities of ReI, ReIII, ReIV, and ReVII, PCR
amplification of these regions was performed with 24 separate
subclones of HSV-1 F, and the sequences of these regions were
compared with those of the amplicons of the parental strains
(Fig. 2). For the regions containing ReIV and ReVII, ampli-
cons from all 24 subclones were identical in size to those of
their parental strains, indicating the stability of ReIV and Re-
VII during the two limiting dilution rounds. For the regions
containing ReI and ReIII, not all separate subclones showed
the same amplicon length as their parental strains, differences
being greatest for ReIII (Fig. 2). Consequently, ReIV and
ReVII were further used to discriminate 37 unrelated HSV-1
isolates obtained from keratitis patients. The results of the
analyses performed with all 37 clinical corneal HSV-1 isolates
are summarized in Table 2. As an example, differences in
amplicon lengths between unrelated clinical isolates from 10
patients are shown in Fig. 3A. The variability in the US10-
US11 region (ReVII) was low, showing only three different
alleles. Regions US1 and US12 (ReIV) showed a wider variety
of alleles, with 14 and 15 different alleles detected among the
37 samples analyzed, respectively (Table 2). Combination of
the results for the three amplified regions showed that 34 of
the 37 isolates (92%) displayed unique combinations of ampli-
cons. For some clinical samples, no PCR product could be
detected by ethidium bromide staining or multiple fragments
appeared. This was probably due to the poor quality of the
template DNA. Hybridization with the labeled probe, how-
ever, readily enabled the detection of the Re-specific amplicon
in these samples (data not shown).
Analysis of sequential corneal HSV-1 isolates. Sequential
corneal HSV-1 isolates obtained from five patients with recur-
rent herpetic corneal infections were analyzed (Fig. 3; Table
2). The ReIV- and ReVII-specific amplicons showed interin-
dividual variations in length. However, the amplicons from the
sequential samples from each individual were identical.
DISCUSSION
In the present paper, we present a PCR-based approach that
allows the rapid and accurate discrimination of unrelated
HSV-1 strains. The method generally used to discriminate
HSV-1 strains is RFLP analysis (7, 15, 17–19, 24, 29–31). This
method requires virus culture, is time-consuming, and is highly
labor-intensive. Furthermore, culture requires viable virus,
which is not always obtainable from certain types of clinical
samples (e.g., cerebrospinal and intraocular fluids). More re-
cently, a system that uses PCR amplification and subsequent
RFLP analysis has been developed to facilitate discrimination
of HSV-1 strains, eliminating the necessity of virus culture.
This method, however, is not significantly less time-consuming
or labor-intensive than conventional strain differentiation (31).
Conventional RFLP analysis with restriction endonucleases
that recognize 6 bp (6-bp REs) is insufficient for differentiation
of HSV-1 strains of a predominant genotype. The use of 4-bp
REs and RFLP analyses of reiterated sequences greatly im-
proved the differentiation rate (28). As in our study, the RFLP
analysis of reiterated sequences was based on various numbers
of repeats. Use of both techniques generated similar results,
verifying the applicability of either method in molecular epi-
demiological studies (27, 28). Similar hypervariable regions
have been used successfully to discriminate strains of other
herpesviruses like Epstein-Barr virus and human cytomegalo-
virus (23, 36).
To be applicable in a PCR-based assay for discrimination of
different HSV-1 strains, these regions should show a consider-
able degree of variability and should remain stable during a















1 215 270 370
2 215 280 220
3 215 280 270
4 215 290 280
5 215 295 230
6 215 305 300
7 220 210 310
8 220 220 220
9 220 220 220
10 220 260 260
11 220 260 290
12 220 260 290
13 220 280 260
14 220 280 260
15 220 290 260
16 220 290 280
17 220 305 230
18 220 305 310
19 220 370 370
20 220 380 300
21 220 380 390
22 220 410 220
23 220 410 460
24 220 420 300
25 220 420 420
26 225 260 270
27 225 260 280
28 225 290 260
29 225 290 270
30 225 295 220
31 225 295 290
32 225 320 220
33 225 320 320
34 225 320 380
35 225 340 220
36 225 340 340
37 225 370 370
Sequential samples
1a 215 280 270
1b 215 280 270
2a 215 280 220
2b 215 280 220
3a 215 295 230
3b 215 295 230
4a 215 305 300
4b 215 305 300
5a 225 220 220
5b 225 220 220
a Three pairs of patients (patients 8 and 9, patients 11 and 12, and patients 13
and 14) were infected with unrelated clinical isolates with identical DNA pat-
terns.
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relatively short time of replication. We tested the suitability of
several HSV-1 hypervariable regions for discrimination of un-
related HSV-1 strains.
Due to their G1C-rich sequences, standard PCR protocols
failed to reproducibly amplify the regions tested. The high
G1C content increases the formation of secondary structures,
preventing consistent amplification of the repeats. We tested a
number of PCR conditions in order to obtain consistent DNA
amplification. Addition of DMSO as a cosolvent to the reac-
tion mixture has previously been shown to facilitate DNA
amplification of G1C-rich sequences (12). Introduction of the
exonuclease activity of the Pfu DNA polymerase enzyme in the
PCR mixture prevents “skipping” of the repeats, which could
result in the formation of products smaller than the actual size
of the template repeat (2). Another modification was the in-
troduction of 7-deaza-29-dGTP. This analogue of dGTP is
equally well incorporated into DNA but exerts a lesser binding
strength to dCTP than normal dGTP (6, 21). The use of Pfu
polymerase, 50% 7-deaza-29-dGTP as a replacement for 100%
dGTP, and 5% DMSO resulted in the most consistent ampli-
fication of the large alleles. The specificities of the amplicons
were confirmed by hybridization with Re-specific probes after
Southern blotting.
Analysis of subclones of HSV-1 F showed that the stability
of the ReI and ReIII sequences was too low to be useful for
discrimination of HSV-1 strains. In contrast, ReIV and ReVII
were shown to be stable during this procedure. Thus, regions
US1 (ReIV), US12 (ReIV), and US10-US11 (ReVII) were
chosen for use in the discrimination of unrelated corneal
HSV-1 isolates.
In agreement with previous studies, the variability in the
US10-US11 region was found to be relatively low (27–29). We
detected only three different alleles among 37 unrelated clin-
ical HSV-1 isolates, which is not surprising since ReVII is
located within a protein-coding region, making it a target for
selective pressure. More drastic changes in the length of US10-
US11 could influence the translation or function of the pro-
teins encoded by genes US10 and US11. In contrast, the ReIV-
containing sequences are located in the introns of genes US1
and US12. We found 14 and 15 different alleles for regions
US1 and US12, respectively, in the 37 corneal HSV-1 isolates
analyzed. Comparison of the alleles from the three regions for
all 37 corneal HSV-1 isolates revealed 34 unique combinations.
The isolates with identical combinations were obtained at dif-
ferent time points, indicating that this was most likely not due
to contamination during virus isolation or culture procedures.
Sequential corneal isolates from five individuals with recur-
rent herpetic corneal infections were analyzed. For each indi-
vidual, sequential samples showed identical DNA patterns,
while the patterns for samples from different patients were
different. These results indicate that the recurrent infections
were most likely caused by the same virus. A comparative
sequence database search revealed several point mutations
between different HSV-1 strains, in addition to various num-
bers of repeats. More detailed analysis, like sequencing of the
amplicons, might provide more conclusive evidence for this
assumption. This also demonstrates that these hypervariable
regions remain stable during reactivation and replication of
latent HSV-1 in the corneas of these individuals.
Additionally, we have also analyzed clinical samples in which
no viable virus can usually be detected (4). Re sequence-spe-
cific PCR analyses were performed with DNA isolated from
affected corneal buttons and rims obtained from patients with
herpetic stromal keratitis during therapeutic keratoplasty. The
FIG. 3. Variability of Re-containing regions US1, US12, and US10-US11 between unrelated and sequential corneal HSV-1 isolates. PCR amplification was
performed with DNA from corneal HSV-1 isolates. Amplicons were analyzed as described in the legend to Fig. 2. (A) Results for 10 representative samples among
the 37 samples analyzed. (B) Amplicons from sequential samples from five individuals. Lane C, water control; lanes M, 100-bp molecular size marker. Numbers on the
left are in base pairs.
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PCR approach proved to be sensitive enough for amplification
of the low levels of viral DNA present in these samples (un-
published data). The major advantage of the approach pre-
sented is that it provides the opportunity to discriminate
HSV-1 strains without virus culture or RFLP analysis, making
it convenient for rapid diagnostic testing. Although not suit-
able for classification of HSV-1 strains, it provides a powerful
tool that can be used to address questions regarding reactiva-
tion and the modes of transmission of HSV-1. For example, it
could be used to assess the risk of HSV-1 transmission through
cornea transplantation and other manifestations of recurrent
HSV-1 infections.
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